Table 1.
Summary of the metabolic engineering optimization strategies used for the production of lycopene in E. coli.
| Major Methods | Optimization Strategies | Yield/Titer | Culture Conditions | References |
|---|---|---|---|---|
| Overexpression of rate-limiting enzymes | Comparison of crtEBI genes from different strains | 59 mg/L | - | [15] |
| Knockout of zwf; overexpression of idi, dxs and ispD, ispF | 7.55 mg/g DCW | Shake-flask fermentation | [28] | |
| Overexpression of crtE, crtB, crtI, ipi, dxs | 5.2 mg/g DCW | Shake-flask fermentation | [29] | |
| Overexpression of dxs, dxr | 22 mg/L | Shake-flask fermentation | [31] | |
| Overexpression of dxs | 1.33 mg/g DCW | Shake-flask fermentation | [32] | |
| The co-expression of appY, crl, and rpoS with dxs | 4.7 mg/g DCW | - | [29] | |
| Directed evolution | Directed evolution of GGPP synthase | 45 mg/g DCW | Shake-flask fermentation | [33] |
| Directed co-evolution of dxs, dxr and idi | 0.65 mg/L | - | [34] | |
| Whole pathway engineering | Expression of the MVA pathway | 4.28 mg/L | Shake-flask fermentation | [35] |
| Type 2 IDI; heterologous MVA pathway | 198 mg/g DCW | Shake-flask fermentation | [36] | |
| Heterologous expression of the MVA pathway | - | Shake-flask fermentation | [37] | |
| Removal of competing pathways | ΔgdhA, ΔaceE, ΔytjC (gpmB), ΔfdhF | 18 mg/g DCW | Batch shake-flask cultivations | [38] |
| Pathway balancing | Combination of gene knockout and overexpression | 2.5 mg/g DCW | - | [20] |
| Genome-wide stoichiometric flux balance analysis; genes knockouts | 6.6 mg/g DCW | Shake-flask fermentation | [39] | |
| Gene knockout (Δhnr, ΔyliE) | - | Shake-flask fermentation | [40] | |
| Regulatory engineering | Ntr regulon, stimulated by excess glycolytic flux through sensing of ACP | 0.16 mg/L/h | Shake-flask fermentation | [41] |
| Engineering of the cAMP receptor protein (CRP) | 18.49 mg/g DCW | Batch fermentation | [42] | |
| Optimization of carbon sources | Auxiliary carbon source optimization | 1050 mg/L | Baffled flask fermentation | [12] |
| Supplementing auxiliary carbon sources | 40 mg/L/h | Fed-batch culture | [43] | |
| Fermentation with fatty acids or waste cooking oils | 94 mg/g DCW | Fed-batch fermentation | [44] | |
| Optimization of fermentation | High cell density fermentation | 220 mg/L | Batch fermentation | [45] |
| Different types of plasmid expression; optimization of fermentation conditions | 67 mg/g DCW | Shake-flask fermentation | [46] | |
| Targeted engineering | Targeted engineering; targeted proteomic and intermediate analysis | 1.23 g/L | Fed-batch fermentation | [47] |
| Two-dimensional search for gene targets | 16 mg/g DCW | Shake-flask fermentation | [48] | |
| Cofactor engineering | Modulating supply of NADPH and ATP; overexpression of dxs, idi and the crt gene operon | 50.6 mg/g DCW | Fed-batch fermentation | [27] |
| Membrane engineering | Membrane engineering; overexpression of plsb, plsc and dgka | 36.4 mg/g DCW | Shake-flask fermentation | [49] |
| Genome engineering | Synthesis genes were integrated into chromosome | 33.43 mg/g DCW | Shake-flask fermentation | [50] |
| Large-scale programming used to optimize the MEP pathway | 9 mg/g DCW | - | [51] | |
| A new combinatorial multi-gene pathway assembly scheme | 448 mg/g DCW | - | [52] |